Anti-β2-glycoprotein IgM antibodies, quantitative, ICL
The test quantitatively determines IgM antibodies to β2-glycoprotein 1, which are antiphospholipid syndrome (APS) markers. These antibodies increase thrombosis and pregnancy complication risk, especially in combination with other autoimmune diseases such as SLE.
Biomaterial: Venous blood
- Draw blood fasting (8-12 hours without food)
- Do not drink water
- Exclude alcohol 24 hours before
- Avoid stress and physical activity 30 minutes before
- If taking anticoagulants, immunomodulators, or hormonal drugs — inform physician.
- Suspected antiphospholipid syndrome;
- unexplained venous or arterial thromboses;
- recurrent miscarriages or pregnancy complications;
- systemic autoimmune diseases;
- disease activity monitoring.
Negative result — IgM anti-β2-glycoprotein antibodies not detected; APS risk low.
Positive result — IgM anti-β2-glycoprotein antibodies detected; characteristic of primary or secondary APS.
Important: results evaluated only together with clinical picture and other laboratory data.
